某院超药品说明书用药情况分析及对策

Analysis and Strategy for Unlabeled Drug Use in a Hospital

目的分析某院超说明书用药情况,并提出相应对策。方法分析某院2015年3月各临床科室超说明书用药情况,将其分类,并根据某院具体情况提出规范超说明书用药对策。结果妇科类药物、呼吸系统用药、激素类药物中超说明书用药的比例排在前3位,分别为12.85%,11.69%,6.43%;抗感染类药物、呼吸系统用药、激素类药物的超说明书使用在超说明书用药中占的比重排在前3位,分别为23.33%,20.30%,12.58%。根据某院情况,制订了"超说明书用药管理制度"并对超说明书用药进行规范。结论只有减少不合理的超说明书用药,规范合理的超说明书用药,才能使超说明书用药既满足临床用药的合理需求,又减少对患者的危害,使药物真正做到安全、有效、经济。

Objective To analyze the unlabeled drug use in the hospital and get the countermeasure. Methods The unlabeled uses of clinical departments in March 2015 was analyzed and classified,on this basis, the countermeasures to the unlabeled drug use was made. Results The first three of unlabeled drug use ratio were gynecological drugs（12. 85% ）, respiratory drugs（11.69% ）, and hormone drugs（6.43% ）. The top three categories were anti-infective drugs（23.33% ）,respiratory drugs（20.30% ）,hormone drugs（12.58% ）. According to these data,the ＂unlabeled uses management institution＂ was drafted out and the unlabeled uses were put into classification management. Conclusion Only by reducing and normalizing the unlabeled uses,can the uses meet the reasonable requirements of clini- cal medicine, and also reduce the harm to patients, as well as making the uses of drugs safe, effective and economic.